Biogen (BIIB) PT Lowered to $284 at Stifel, Following Earnings
Tweet
Share
E-mail
Get Alerts BIIB Hot Sheet
Price: $209.15 --0%
Rating Summary:
28 Buy, 15 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 9 | New: 20
Rating Summary:
28 Buy, 15 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 9 | New: 20
Join SI Premium – FREE
Stifel analyst Paul Matteis lowered the price target on Biogen (NASDAQ: BIIB) to $284.00 (from $294.00) while maintaining a Hold rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Alpha Cognition Inc (ACOG) PT Raised to $20 at H.C. Wainwright
- SharpLink Gaming (SBET) PT Lowered to $8 at Canaccord
- National Australia Bank Ltd. (NAB:AU) (NABZY) PT Lowered to AUD39.90 at JPMorgan
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
Stifel, EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
